ES2156143T3 - Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas. - Google Patents

Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.

Info

Publication number
ES2156143T3
ES2156143T3 ES94403038T ES94403038T ES2156143T3 ES 2156143 T3 ES2156143 T3 ES 2156143T3 ES 94403038 T ES94403038 T ES 94403038T ES 94403038 T ES94403038 T ES 94403038T ES 2156143 T3 ES2156143 T3 ES 2156143T3
Authority
ES
Spain
Prior art keywords
polyaminated
ligands
diagnostic
therapeutic applications
preparation procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94403038T
Other languages
English (en)
Inventor
Dominique Meyer
Olivier Rousseaux
Michel Schaeffer
Christian Simonot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet SA
Original Assignee
Guerbet SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet SA filed Critical Guerbet SA
Application granted granted Critical
Publication of ES2156143T3 publication Critical patent/ES2156143T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

LA INVENCION SE REFIERE A DERIVADOS DE POLI(AMINOACIDOS) QUELADORES DE IONES METALICOS PARAMAGNETICOS 3 ATOMOS AL MENOS DE NITROGEO DONANTES LLEVAN SUSTITUYENTES,IDENTICOS O DIFERENTES DE FORMULA CH(R1)-X EN LA QUE X REPRESENTA CO2R, CONRBRC O P(RD)O2H, Y RA, RB, RC IDENTICOS O DIFERENTES REPRESENTAN H O (C1-C8)ALKILO, EVENTUALMENTE HIDROXILADO; RD REPRESENTA OH, (C1-C8)ALKILO O (C1-C8)ALKOXI; Y R1 REPRESENTA UN GRUPO HIDROFILO DE MASA MOLECULAR SUPERIOR A 200, QUE COMPRENDE AL MENOS 3 ATOMOS DE OXIGENO QUE SE ENTIENDEN COMO 3 DE LOS GRUPOS X SON FUNCIONES ACIDAS, EVENTUALMENTE SALIFICADAS.
ES94403038T 1993-12-30 1994-12-27 Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas. Expired - Lifetime ES2156143T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9315933 1993-12-30

Publications (1)

Publication Number Publication Date
ES2156143T3 true ES2156143T3 (es) 2001-06-16

Family

ID=9454621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94403038T Expired - Lifetime ES2156143T3 (es) 1993-12-30 1994-12-27 Ligandos poliaminados, complejos metalicos, procedimiento de preparacion, aplicaciones diagnosticas y terapeuticas.

Country Status (19)

Country Link
US (2) US5712389A (es)
EP (1) EP0661279B1 (es)
JP (1) JP3862299B2 (es)
KR (1) KR100328575B1 (es)
CN (1) CN1056162C (es)
AT (1) ATE199550T1 (es)
AU (1) AU687120B2 (es)
CA (1) CA2139374C (es)
CZ (1) CZ289751B6 (es)
DE (1) DE69426811T2 (es)
DK (1) DK0661279T3 (es)
ES (1) ES2156143T3 (es)
FI (1) FI113171B (es)
GR (1) GR3035913T3 (es)
IL (1) IL112175A (es)
NO (1) NO306721B1 (es)
NZ (1) NZ270289A (es)
PT (1) PT661279E (es)
ZA (1) ZA9410382B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426811T2 (de) * 1993-12-30 2001-09-13 Guerbet, Villepinte Polyaminierte Liganden, Metallkomplexe, Verfahren zur Herstellung und diagnostische und therapeutische Verwendungen
ZA958789B (en) * 1994-10-21 1996-05-29 Nihon Mediphysics Co Ltd Diagnostic imaging agent
TW319763B (es) 1995-02-01 1997-11-11 Epix Medical Inc
US6713045B1 (en) 1995-06-02 2004-03-30 Research Corporation Technologies, Inc. Targeted magnetic resonance imaging agents for the detection of physiological processes
US6770261B2 (en) 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
IT1283218B1 (it) 1996-03-08 1998-04-16 Bracco Spa Polichelanti, loro complessi con ioni metallici, loro preparazione e loro usi
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
AU752812B2 (en) 1997-11-17 2002-10-03 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
FR2772025B1 (fr) * 1997-12-10 2000-03-03 Guerbet Sa Chelates metalliques de macrocycles polyaminocarboxyliques et leur application a l'imagerie par resonance magnetique
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
US6685915B2 (en) * 1999-12-01 2004-02-03 General Electric Company Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging
US20040170562A1 (en) * 1999-12-01 2004-09-02 Uzgiris Egidijus Edward Extended-linear polymeric contrast agents, and synthesizing methods, for medical imaging
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
AU2001276956A1 (en) 2000-07-17 2002-01-30 California Institute Of Technology Macrocyclic mri contrast agents
WO2002028441A2 (en) 2000-10-04 2002-04-11 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
EP1390079A2 (en) 2000-11-20 2004-02-25 Board of Regents University of Texas System Paramagnetic metal ion-based macrocylic contrast agents
US20030050452A1 (en) * 2000-12-26 2003-03-13 Yuji Hashiguchi Process for producing metal complex of aminooligosaccharide derivative
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
DE10135356C1 (de) * 2001-07-20 2003-04-17 Schering Ag Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
FR2829493B1 (fr) * 2001-09-10 2005-08-05 Commissariat Energie Atomique Composes thermosensibles presentant un point de trouble, utilisables comme extractants pour la separation de metaux en solution aqueuse
EP1369134A1 (en) * 2002-06-05 2003-12-10 Bracco Imaging S.p.A. New agents for magnetic imaging method
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
US20040022857A1 (en) * 2002-07-31 2004-02-05 Uzgiris Egidijus E. Synthesis of highly conjugated polymers
FR2856063B1 (fr) * 2003-06-13 2005-10-07 Air Liquide Procede de preparation du cis-8b-methyldecahydro-2a,4a,6a, 8a-tetraazacyclopenta[fg]acenaphthylene,ou du cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta[fg] acenaphthylene, du cyclene, et de cyclenes fonctionnalises
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
FR2857967B1 (fr) * 2003-07-25 2015-04-24 Centre Nat Rech Scient Complexes de lanthanide, leur preparation et leurs utilisations
FR2867473B1 (fr) 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
CN1993357B (zh) * 2004-07-02 2011-10-19 伯拉考成像股份公司 用于磁共振成像(mri)的含有具有多羟基化取代基的螯合部分的高弛豫造影剂
CA2581639C (en) 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
WO2006121889A2 (en) * 2005-05-06 2006-11-16 Epix Pharmaceuticals, Inc. Chemical exchange saturation transfer contrast agents
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
CA2625196C (fr) 2005-10-07 2016-04-05 Guerbet Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
EP1964846A1 (en) * 2007-02-27 2008-09-03 Bracco Imaging, S.P.A. Process for the preparation of contrast agents
FR2914304B1 (fr) 2007-03-28 2012-11-16 Guerbet Sa Composes pour le diagnostic de maladies liees a l'expression de vcam.
FR2914303A1 (fr) 2007-03-28 2008-10-03 Guerbet Sa Composes pour le diagnostic de l'apoptose.
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
JP5735791B2 (ja) * 2010-12-07 2015-06-17 住友化学株式会社 金属錯体を含む素子
EP2890951A4 (en) 2012-08-15 2016-05-18 Nova Measuring Instr Ltd OPTICAL METROLOGY FOR IN-SITU MEASUREMENTS
US20160287726A1 (en) * 2015-04-06 2016-10-06 The Trustees Of The University Of Pennsylvania Cationic contrast agents and methods of using the same
WO2017165841A1 (en) 2016-03-25 2017-09-28 Nanoprobes, Inc. Iodine-based particles
WO2025045168A1 (zh) 2023-09-01 2025-03-06 江苏恒瑞医药股份有限公司 一种大环化合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
EP0484989B1 (en) * 1986-09-05 1996-04-24 GANSOW, Otto A. Polysubstituted diethylenetriamine chelates for forming a metal-chelate-protein conjugate
JP2831073B2 (ja) * 1988-06-24 1998-12-02 ザ ダウ ケミカル カンパニー 大環状二官能キレート剤、その錯体及びそれらの抗体接合体
JPH03504510A (ja) * 1989-02-10 1991-10-03 セルテック　リミテッド アザマクロサイクルおよびその製法
DE4035760A1 (de) * 1990-11-08 1992-05-14 Schering Ag Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5141740A (en) * 1990-11-21 1992-08-25 Mallinckrodt Medical, Inc. Complexes and compositions for magnetic resonance imaging and usage methods
JPH0565930A (ja) * 1991-09-06 1993-03-19 Kayaba Ind Co Ltd フロントフオーク
CA2092596A1 (en) * 1992-03-27 1993-09-28 Kan Kubomura Tetraazacyclododecane derivative and its use
DE69426811T2 (de) * 1993-12-30 2001-09-13 Guerbet, Villepinte Polyaminierte Liganden, Metallkomplexe, Verfahren zur Herstellung und diagnostische und therapeutische Verwendungen

Also Published As

Publication number Publication date
DE69426811T2 (de) 2001-09-13
ZA9410382B (en) 1996-06-29
FI946157L (fi) 1995-07-01
JPH07224050A (ja) 1995-08-22
KR950017976A (ko) 1995-07-22
IL112175A (en) 1999-08-17
GR3035913T3 (en) 2001-08-31
EP0661279A1 (fr) 1995-07-05
FI113171B (fi) 2004-03-15
JP3862299B2 (ja) 2006-12-27
NO306721B1 (no) 1999-12-13
CN1110974A (zh) 1995-11-01
EP0661279B1 (fr) 2001-03-07
CA2139374A1 (en) 1995-07-01
CN1056162C (zh) 2000-09-06
CA2139374C (en) 2007-11-20
IL112175A0 (en) 1995-03-15
NO945069D0 (no) 1994-12-29
AU8178094A (en) 1995-07-06
US5712389A (en) 1998-01-27
DE69426811D1 (de) 2001-04-12
CZ332294A3 (en) 1995-07-12
AU687120B2 (en) 1998-02-19
KR100328575B1 (ko) 2002-11-16
ATE199550T1 (de) 2001-03-15
FI946157A0 (fi) 1994-12-29
DK0661279T3 (da) 2001-07-16
PT661279E (pt) 2001-06-29
NZ270289A (en) 1996-05-28
US5919432A (en) 1999-07-06
NO945069L (no) 1995-07-03
CZ289751B6 (cs) 2002-03-13

Similar Documents

Publication Publication Date Title
GR3035913T3 (en) Polyaminated ligands, metal complexes, process for their preparation and diagnostic and therapeutic applications.
AU684453C (en) Cascade polymer bound chelating compounds, their chelates and conjugates, processes for their production, and pharmaceutical agents containing them
MX9709913A (es) Metaloconstrucciones determinadas estructuralmente y aplicaciones.
DK1060163T3 (da) Nye piperazinyl-substituerede pyridylalkan-, -alken og -alkyncarboxamider
ATE273041T1 (de) Biologisch-abbaubare anionische polymere, die sich von der aminosäure l-tyrosin herleiten
DE60029389D1 (de) Klebstoffzusammensetzung und Verfahren zu ihrer Herstellung
DK0730574T3 (da) Fremgangsmåder og katalysatorsammensætninger til hydrocyanering af monoolefiner
ES2060002T3 (es) Compuestos formadores de quelatos para la complejacion de isotopos radiactivos, sus complejos con metales, asi como su utilizacion en diagnostico y terapia.
ES8103027A1 (es) Un procedimiento para la preparacion de un polipeptido
NO178571C (no) Analogifremgangsmåte for fremstilling av et bifunksjonelt chelateringsmiddel
ATE250641T1 (de) Ungeordnete siloxan-copolymer, verfahren zur herstellung und diesen copolymer enthaltende zusammensetzung
DE59009817D1 (de) Neuartige monomerbausteine aus hydroxyfettsäuren zur herstellung von kunststoffen.
NO175313C (no) Joderte polymerer og deres anvendelse
ES2030449T3 (es) Procedimiento para la preparacion de polimeros acrilicos imidizados.
DE59010838D1 (de) Glycosyl-Etoposid-Prodrugs, Verfahren zu ihrer Herstellung und ihre Anwendung in Kombination mit funktionalisierten tumorspezifischen Enzym-Konjugaten
DE69314620D1 (de) Verfahren zur Herstellung von Polymeren basierend auf Kohlenmonoxyd und Olefinen
DK0401623T3 (da) Fremgangsmåde til fremstilling af 7-(3-amino- og 3-aminomethyl-1-pyrrolidinyl)-3-quinoloncarboxylsyrer og -napthyridoncarbo
ES2038665T3 (es) Procedimiento de sintesis de penems.
DE3854266D1 (de) Verfahren zur Modifizierung eines Molekularsiebes.
DE3573121D1 (en) Diacylderivatives of glycerylphosphorylcholine having therapeutical activity, a process for their preparation and related pharmaceutical compositions
WO1997000127A3 (en) Catalyst composition and process for the preparation of copolymers of carbon monoxide and an olefinically unsaturated compound
MY106165A (en) Catalyst compositions and polymerization process, hexakisphosphines and hexahalo compounds
ATE105293T1 (de) Phosphortrilactame und verfahren zu deren herstellung.
ATE181561T1 (de) Verfahren zur herstellung von copolymeren aus kohlenmonoxid und mindestens einer verbindung mit olefinischer ungesättigtheit
DK0700930T3 (da) Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661279

Country of ref document: ES